Grace Therapeutics Inc
Grace Therapeutics Inc (GRCE) Covered Calls
As of September 25, 2026, GRCE has 4 covered call opportunities in the coming three months. Return ranges from 20.3 to 32.1% until expiration. Annualized return ranges from 49.2 to 352.5%. The nearest expiration is October 16, 2026. Maximum potential profit is $68.
Read more
Running GRCE covered calls helps you generate consistent income from Grace Therapeutics Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Grace Therapeutics Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best GRCE covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if GRCE stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling GRCE covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Grace Therapeutics Inc covered call is worth writing.
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Income-focused investors, long-term GRCE holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling GRCE covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Grace Therapeutics Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)45
- 52 weeks high-59.07%
- 52 weeks low18.44%
- Analyst recommendationStrong Buy
1.00 - Target price$6.00
183.02% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-1.18
- EPS growth next 5 years—
As of September 25, 2026
| 2026-10-16 | 21 | 2.50 | 17.92 | 0.05 | 0.15 | 43.00 | 20.28 | 352.54 | -2.36 | +0.32 | 2 | 0.10 |
| 2026-11-20 | 56 | 2.50 | 17.92 | 0.05 | 0.20 | 43.00 | 20.28 | 132.20 | -2.36 | +0.35 | 2,773 | 0.15 |
| 2027-02-19 | 147 | 2.50 | 17.92 | 0.20 | 0.50 | 58.00 | 27.36 | 67.93 | -9.43 | +0.50 | 73 | 0.30 |
| 2027-05-21 | 238 | 2.50 | 17.92 | 0.30 | 2.50 | 68.00 | 32.08 | 49.19 | -14.15 | +0.82 | 11 | 2.20 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best GRCE covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→